A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Therapy

Prostate cancer (PCa) is the second most common cancer in men, causing more than 300,000 deaths every year worldwide. Due to their superior cell-killing ability and the relative simplicity of their preparation, immunotoxin molecules have great potential in the clinical treatment of cancer, and sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Yutong, Xu, Keyuan, Li, Shixiong, Cao, Li, Nan, Yue, Li, Qiyu, Li, Wenjing, Hong, Zhangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197099/
https://www.ncbi.nlm.nih.gov/pubmed/34071152
http://dx.doi.org/10.3390/ijms22115501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197099/
https://www.ncbi.nlm.nih.gov/pubmed/34071152
http://dx.doi.org/10.3390/ijms22115501

Ejemplares similares